Cargando…
Application of the Multi-Omics Liquid Biopsy Method M2P-HCC in Early Liver Cancer Screening for High-Risk Individuals with Hepatitis B-Related Liver Cancer
Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide, with low rates of early diagnosis and surgical resection. In recent years, with the rapid development of liquid biopsy technology, circulating tumor DNA (ctDNA) has emerged as a research hotspot in the f...
Autores principales: | Yu, Xian, Lei, Xuezhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417463/ https://www.ncbi.nlm.nih.gov/pubmed/37568847 http://dx.doi.org/10.3390/diagnostics13152484 |
Ejemplares similares
-
Liquid biopsies and cancer omics
por: Amelio, Ivano, et al.
Publicado: (2020) -
The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions
por: Ugonabo, Onyinye, et al.
Publicado: (2023) -
Editorial: The impact of liquid biopsies in the management of liver cancer
por: Labgaa, Ismail
Publicado: (2022) -
Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020) -
Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC
por: Liu, Lei, et al.
Publicado: (2022)